Australia markets closed

Botanix Pharmaceuticals Limited (BOT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.33500.0000 (0.00%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 527.67M
Enterprise value 518.99M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.92k
Price/book (mrq)11.63
Enterprise value/revenue 5.59k
Enterprise value/EBITDA -11.08

Trading information

Stock price history

Beta (5Y monthly) 1.91
52-week change 3219.05%
S&P500 52-week change 325.22%
52-week high 30.3550
52-week low 30.1050
50-day moving average 30.2646
200-day moving average 30.1932

Share statistics

Avg vol (3-month) 34.43M
Avg vol (10-day) 35.83M
Shares outstanding 51.58B
Implied shares outstanding 61.58B
Float 81.3B
% held by insiders 116.23%
% held by institutions 19.80%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 316 June 2016

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-1,462.26%

Management effectiveness

Return on assets (ttm)-18.33%
Return on equity (ttm)-32.25%

Income statement

Revenue (ttm)437.21k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-89.80%
Gross profit (ttm)N/A
EBITDA -10.02M
Net income avi to common (ttm)-10.02M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.31M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.50
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-10.1M
Levered free cash flow (ttm)-22.12M